source Post navigation FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight … – Investors | Eli Lilly and Company Florida faces diabetes ‘epidemic’ as number outpaces national average, St. Pete doctor says – FOX 13 Tampa